ArticleSignal transduction and targeted therapy2020

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.

Fanping Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.